Apolipoprotein M gene (APOM) polymorphism modifies metabolic and disease traits in type 2 diabetes

PLoS ONE

Volumn 6, Issue 2, 2011, Pages

  Zhou, Jun Wei ^a   Tsui, Stephen K W ^a   Ng, Maggie C Y ^b   Geng, Hua ^c   Li, Sai Kam ^a   So, Wing Yee ^a   Ma, Ronald C ^a   Wang, Ying ^a   Tao, Qian ^c   Chen, Zhen Yu ^a   Chan, Juliana C N ^a   Ho, Yuan Yuan ^a,d  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN M; APOLIPOPROTEIN M1; APOLIPOPROTEIN M5; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; APOM PROTEIN, HUMAN; LIPOCALIN;

ADULT; ALLELE; ARTICLE; CHINESE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CONTROLLED STUDY; DISEASE DURATION; EXON; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE STRUCTURE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC TRANSCRIPTION; GENOTYPE; HOMEOSTASIS; HONG KONG; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE SPECIFICITY; AGED; ASIAN; CASE CONTROL STUDY; COHORT ANALYSIS; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; PHENOTYPE; PHYSIOLOGY;

ADULT; AGED; APOLIPOPROTEINS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LIPOCALINS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 79952091697     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0017324     Document Type: Article

References (28)

1. Dahlback B, Nielsen LB, (2006) Apolipoprotein M-a novel player in high-density lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 17: 291-295.
2. Xu N, Dahlback B, (1999) A novel human apolipoprotein (apoM). J Biol Chem 274: 31286-31290.
3. Ooi EM, Watts GF, Chan DC, Nielsen LB, Plomgaard P, et al. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men. Atherosclerosis 210: 326-330.
4. Wolfrum C, Poy MN, Stoffel M, (2005) Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med 11: 418-422.
5. Kruit JK, Kremer PH, Dai L, Tang R, Ruddle P, et al. Cholesterol efflux via ATP-binding cassette transporter A1 (ABCA1) and cholesterol uptake via the LDL receptor influences cholesterol-induced impairment of beta cell function in mice Diabetologia 53: 1110-1119.
6. Xiang K, Wang Y, Zheng T, Jia W, Li J, et al. (2004) Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 53: 228-234.
7. Jiao GQ, Yuan ZX, Xue YS, Yang CJ, Lu CB, et al. (2007) A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese. Clin Biochem 40: 1108-1112.
8. Niu N, Zhu X, Liu Y, Du T, Wang X, et al. (2007) Single nucleotide polymorphisms in the proximal promoter region of apolipoprotein M gene (apoM) confer the susceptibility to development of type 2 diabetes in Han Chinese. Diabetes Metab Res Rev 23: 21-25.
9. Zhao TM, Lee TD, (1989) Gm and Km allotypes in 74 Chinese populations: a hypothesis of the origin of the Chinese nation. Hum Genet 83: 101-110.
10. Alberti KG, Zimmet PZ, (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553.
11. Yang X, So WY, Kong AP, Ho CS, Lam CW, et al. (2007) Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care 30: 65-70.
12. Sambrook J, Russell DW, (2001) Molecular cloning. Cold Spring Harbor, N.Y. Cold Spring Harbor Laboratory Press pp. 3 bd.
13. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
14. Su W, Jiao G, Yang C, Ye Y, (2009) Evaluation of apolipoprotein M as a biomarker of coronary artery disease. Clin Biochem 42: 365-370.
15. Skupien J, Kepka G, Gorczynska-Kosiorz S, Gebska A, Klupa T, et al. (2007) Evaluation of Apolipoprotein M Serum Concentration as a Biomarker of HNF-1alpha MODY. Rev Diabet Stud 4: 231-235.
16. Geng H, Liu YM, Chan WS, Lo AW, Au DM, et al. (2005) The putative protein 6 of the severe acute respiratory syndrome-associated coronavirus: expression and functional characterization. FEBS Lett 579: 6763-6768.
17. Bligh EG, Dyer WJ, (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917.
18. Wheeler DL, Barrett T, Benson DA, Bryant SH, Canese K, et al. (2008) Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 36: D13-21.
19. Stenger JE, Xu H, Haynes C, Hauser ER, Pericak-Vance M, et al. (2005) Statistical Viewer: a tool to upload and integrate linkage and association data as plots displayed within the Ensembl genome browser. BMC Bioinformatics 6: 95.
20. Ovcharenko I, Nobrega MA, Loots GG, Stubbs L, (2004) ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res 32: W280-286.
21. Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, et al. (2008) Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene 27: 5267-5276.
22. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF, (1998) Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: molecular analysis of primary tumor tissue. Blood 91: 1373-1381.
23. Tao Q, Huang H, Geiman TM, Lim CY, Fu L, et al. (2002) Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet 11: 2091-2102.
24. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
25. Han XJ, Jia JP, (2007) [Distribution characters and linkage disequilibrium analysis of APOM gene polymorphisms in Han population of North China]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 24: 350-353.
26. Zhao D, He Z, Qin X, Li L, Liu F, et al. Association of Apolipoprotein M Gene Polymorphisms with Ischemic Stroke in a Han Chinese Population J Mol Neurosci in press.
27. Xu N, Nilsson-Ehle P, Ahren B, (2004) Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects. J Nutr Biochem 15: 579-582.
28. Richter S, Shih DQ, Pearson ER, Wolfrum C, Fajans SS, et al. (2003) Regulation of apolipoprotein M gene expression by MODY3 gene hepatocyte nuclear factor-1alpha: haploinsufficiency is associated with reduced serum apolipoprotein M levels. Diabetes 52: 2989-2995.